Notice: 21423534
Final Adopted Version in F.A.C.
Department: DEPARTMENT OF LEGAL AFFAIRS
Chapter: SCHEDULING AND RESCHEDULING OF CONTROLLED SUBSTANCES

VIEW NOTICE

Overview

RULE:
2-40.007   Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) Derived from Cannabis and No More Than 0.1 Percent (w/w) Residual Tetrahydrocannabinols
RULE FILE DATE: 1/18/2019
RULE EFFECTIVE DATE: 2/7/2019
HISTORY NOTES: Rulemaking Authority 893.0355 FS. Law Implemented 893.0355 FS. History–New 2-7-19.

OVERSIGHT COMMITTEE: Joint Administrative Procedures Committee
Florida Administrative Law Central Online Network (F.A.L.C.O.N.)

RELATED COURT CASES: Division of Administrative Hearings

FEDERAL RULES
AND REGULATIONS:
Electronic Code of Federal Regulations

HOW TO LINK TO
THIS NOTICE:
http://flrules.org/gateway/ruleno.asp?id=2-40.007&Section=0
REFERENCE MATERIALS: No reference(s).